FDA inspection
Braintree, A part of SEBELA Pharmaceuticals: FDA inspection ending Oct 22, 2019
FDA inspection 1107155 · Holbrook, MA
Key facts
| Inspection ID | 1107155 |
|---|---|
| Firm | Braintree, A part of SEBELA Pharmaceuticals |
| FEI number | 1000513636 |
| Address | 270 Centre St |
| City | Holbrook |
| State | MA |
| ZIP | 02343-1073 |
| Fiscal year | 2020 |
| Inspection end date | Oct 22, 2019 |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data